Taysha Gene Therapies Inc (TSHA)
4.67
-4.50%
Taysha Gene Therapies Inc (TSHA) is currently trading at $4.67. This represents a loss of 4.5% from the previous session. With a market capitalization of $1.29B, TSHA is a key component of the Health Care sector. Investors looking to trade TSHA should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade TSHA commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Taysha Gene Therapies Inc (TSHA) shows a bearish trend. Analysts are watching the 5.07 level closely.
Fundamentals
Mkt Cap1.29B
P/E Ratio0.0000
Volume1,631,832
60-Day Technical Chart
Advanced Charting
Need more indicators for TSHA? Use the world's #1 platform.
Open TSHA on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $5
| Metric |
TSHA -4.50% |
OPEN -2.54% |
SNAP +2.01% |
AUR +0.62% |
|---|---|---|---|---|
| Price | $4.67 | $4.98 | $5.07 | $4.88 |
| Mkt Cap | $1.29B | $4.74B | $8.54B | $9.52B |
| - | View → | View → | View → |
Latest Headlines
Taysha Gene Therapies (TSHA): Assessing Valuation Following Strong Share Price Gains
Yahoo Finance • Nov 4, 2025
$TSHA stock is down 13% today. Here's what we see in our data.
Quiver Quantitative • Nov 3, 2025
New gene therapy trial progresses for children and adults with Rett syndrome
Stock Titan • Jan 6, 2026
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • Feb 6, 2026
Taysha Gene Therapies stock hits 52-week high at 5.51 USD
Investing.com • Dec 8, 2025
● Gemini Agentic AI Analyst Insight for TSHA
Market Education
- Stocks Pivot - Trending Up Dec 10, 2023
- Long Short Strategy to Manage Risk May 31, 2024
- Fed talking about Phillips Curve - I want to know what it is and how it impacts the interest rate Jul 18, 2023
External Research